Global Biopsy Device Market Report By Product (Needle-based Biopsy Instruments (Core Biopsy Devices, Aspiration Biopsy Noodles , Vacuum-assisted Biopsy Devices), Localization Wires, Procedure Trays), By Guidance Technique (Ultrasound-guided Biopsy, Stereotactic guided Biopsy, MRI-guided Biopsy, Others), By Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others), By End User (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032

As per this study the Global Biopsy Device Market was valued USD 3.42 BN (by revenue) in 2022 and is anticipated to reach USD 6.24 BN by 2030 with a CAGR of 7.8%.
 
A biopsy is referred to as the medical procedure to remove of the tissue or body fluids from suspicious body part for laboratory examination. Devices such as biopsy needles, forceps, curettes, localization wires, procedure trays and others carry out the biopsy. These are crucial components while performing a needle biopsy, endoscopic biopsy, CT guided biopsy, ultrasound-guided biopsy, aspiration biopsy and surgical biopsy to diagnose tumor within various body parts.
 
Market Dynamics
 
The rapid proliferation of various types of cancer worldwide is predominantly driving the demand for biopsy devices. The growing demand of frequent biopsies in kidney diseases, infectious diseases, and metabolic diseases is further pushing the market growth higher. Advancement in biopsy procedure followed by favorable reimbursement policies especially for cancer treatment is again boosting the market growth. However, the high cost of devices and lack of skilled medical professional may hinder the market growth. Nevertheless, ongoing research for development of less expensive devices is predicted to upsurge the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of biopsy device.
 
Market Segmentation
 
The broad biopsy device market has been sub-grouped into product and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 

By Product

• Needle-based Biopsy Instruments (Core Biopsy Devices, Aspiration Biopsy Noodles , Vacuum-assisted Biopsy Devices)
• Localization Wires
• Procedure Trays

By Guidance Technique

• Ultrasound-guided Biopsy
• Stereotactic guided Biopsy 
• MRI-guided Biopsy
• Others

By Application

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

By End User

• Hospitals
• Academic and Research Institutes
• Diagnostic and Imaging Centers

 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for biopsy device in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Biopsy Device Market Share by Region (Representative Graph)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the biopsy device market include C. R. Bard Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Blosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD Inc. (US), and Meatronic plc (Ireland). An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.